Close

Concert Pharma (CNCE) Misses Q1 EPS by 12c

May 5, 2022 7:29 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($1.03), $0.12 worse than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings